Drug
Megnesium Oxide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hypomagnesaemia | 11 | 40.3 | 41.4 | signal |
| 2 | Lymphopenia | 9 | 32.5 | 33.2 | signal |
| 3 | Thrombotic Microangiopathy | 6 | 31.5 | 31.9 | signal |
| 4 | Hepatocellular Injury | 8 | 28.6 | 29.1 | signal |
| 5 | Petechiae | 5 | 24.4 | 24.7 | signal |
| 6 | Hypocalcaemia | 9 | 24.2 | 24.7 | signal |
| 7 | Cholestasis | 9 | 23.9 | 24.4 | signal |
| 8 | Agranulocytosis | 6 | 16.5 | 16.7 | signal |
| 9 | Posterior Reversible Encephalopathy Syndrome | 3 | 16.0 | 16.1 | signal |
| 10 | Toxic Skin Eruption | 3 | 15.1 | 15.2 | signal |
| 11 | Myelodysplastic Syndrome | 4 | 14.0 | 14.2 | signal |
| 12 | Drug Reaction With Eosinophilia And Systemic Symptoms | 7 | 13.9 | 14.1 | signal |